Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.754
-0.006 (-0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
0.757
+0.003 (0.44%)
After-hours: Apr 28, 2026, 7:16 PM EDT
Mustang Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 3.95 | 4.14 | 9.69 | 12.21 | 11.02 | |
| Research & Development | -1.52 | 8.42 | 41.04 | 63.95 | 55.71 | |
| Operating Expenses | 2.43 | 12.55 | 50.73 | 76.16 | 66.72 | |
| Operating Income | -2.43 | -12.55 | -50.73 | -76.16 | -66.72 | |
| Interest Expense | - | - | -4.11 | -3.36 | -0.02 | |
| Interest & Investment Income | 0.51 | 0.18 | 0.85 | 0.69 | 0.37 | |
| Other Non Operating Income (Expenses) | - | 0.31 | 0.72 | 1.3 | - | |
| EBT Excluding Unusual Items | -1.92 | -12.06 | -53.27 | -77.53 | -66.37 | |
| Gain (Loss) on Sale of Assets | - | - | 1.47 | - | - | |
| Asset Writedown | - | -3.69 | - | - | - | |
| Other Unusual Items | - | - | 0.2 | - | - | |
| Pretax Income | -1.92 | -15.75 | -51.6 | -77.53 | -66.37 | |
| Net Income | -1.92 | -15.75 | -51.6 | -77.53 | -66.37 | |
| Net Income to Common | -1.92 | -15.75 | -51.6 | -77.53 | -66.37 | |
| Shares Outstanding (Basic) | 5 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 5 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 705.02% | 254.41% | 11.93% | 31.16% | 67.12% | |
| EPS (Basic) | -0.39 | -25.84 | -299.96 | -504.42 | -566.39 | |
| EPS (Diluted) | -0.39 | -25.84 | -299.96 | -504.42 | -566.39 | |
| Free Cash Flow | -5.26 | -11.41 | -49.54 | -67.78 | -57.65 | |
| Free Cash Flow Per Share | -1.07 | -18.71 | -287.98 | -441.02 | -492.00 | |
| EBITDA | -2.4 | -11.88 | -48.87 | -73.44 | -64.56 | |
| D&A For EBITDA | 0.03 | 0.67 | 1.86 | 2.72 | 2.17 | |
| EBIT | -2.43 | -12.55 | -50.73 | -76.16 | -66.72 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.